Smith & Nephew plc (NYSE:SNN) Given Average Rating of “Moderate Buy” by Analysts

Smith & Nephew plc (NYSE:SNN) has been given an average rating of “Moderate Buy” by the five brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company.

A number of analysts recently weighed in on SNN shares. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft started coverage on Smith & Nephew in a research note on Wednesday, July 24th. They issued a “buy” rating on the stock.

Smith & Nephew Stock Performance

NYSE:SNN opened at $28.62 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. Smith & Nephew has a 12-month low of $21.52 and a 12-month high of $31.72. The stock’s 50 day simple moving average is $30.43 and its 200-day simple moving average is $27.43.

Institutional Trading of Smith & Nephew

Institutional investors have recently bought and sold shares of the company. Nomura Holdings Inc. purchased a new stake in Smith & Nephew during the fourth quarter worth $887,000. Lorne Steinberg Wealth Management Inc. boosted its position in Smith & Nephew by 53.6% during the second quarter. Lorne Steinberg Wealth Management Inc. now owns 231,045 shares of the medical equipment provider’s stock worth $5,725,000 after purchasing an additional 80,650 shares in the last quarter. Clearbridge Investments LLC purchased a new stake in Smith & Nephew during the first quarter worth $2,612,000. Tocqueville Asset Management L.P. boosted its position in Smith & Nephew by 294.9% during the first quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock worth $5,692,000 after purchasing an additional 167,599 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after purchasing an additional 964,762 shares in the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.